Insider Shareholders with Direct Ownership of Verve Therapeutics, Inc. (VERV)
This section provides a comprehensive overview of the insiders with direct ownership of Verve Therapeutics, Inc. (VERV). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Verve Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Wellington Biomedical Innovation Master Investors (Cayman) I L.P.
> 10% Shareholder |
2,495,571 | 0 | 2,495,571 $14.3 Million | 1 |
Jun 21, 2021
Added 31.59%
|
|
Casdin Partners Master Fund, L.P.
> 10% Shareholder |
2,417,596 | 0 | 2,417,596 $13.9 Million | 1 |
Jun 21, 2021
Added 31.27%
|
|
Broad Institute, Inc.
> 10% Shareholder |
387,830 | 0 | 809,784 $4.64 Million | 1 |
Jun 21, 2021
Added 32.38%
|
|
Novo Holdings
> 10% Shareholder |
793,265 | 0 | 793,265 $4.55 Million | 1 |
Jun 21, 2021
Added 30.61%
|
|
Casdin Private Growth Equity Fund, L.P.
> 10% Shareholder |
620,571 | 0 | 620,571 $3.56 Million | 1 |
Jun 21, 2021
Added 50.0%
|
|
Beam Therapeutics Inc.
> 10% Shareholder |
270,895 | 0 | 546,970 $3.13 Million | 1 |
Jun 21, 2021
Added 33.12%
|
|
Logos Global Management Lp
> 10% Shareholder |
370,000 | 0 | 370,000 $2.12 Million | 1 |
Jun 21, 2021
Added 50.0%
|
|
Sekar Kathiresan
Chief Executive Officer |
416,737 | 474,563 | 351,128 $2.01 Million | 20 |
Jun 28, 2024
Added 7.87%
|
| 175,787 | 0 | 342,509 $1.96 Million | 3 |
May 14, 2024
Added 18.16%
|
|
|
Andrew Bellinger
Chief Scientific Officer |
156,000 | 115,865 | 42,629 $244,264 | 13 |
Dec 14, 2022
Added 45.78%
|
|
Joan Nickerson
Chief Administrative Officer |
3,315 | 1,514 | 8,659 $49,616 | 2 |
Apr 02, 2024
Reduced 14.88%
|
|
Allison Dorval
Chief Financial Officer |
3,750 | 1,108 | 4,060 $23,263 | 4 |
Nov 29, 2023
Reduced 12.01%
|
|
Margaret Beaudoin
Vice President, Finance |
1,000 | 0 | 1,000 $5,730 | 1 |
Jun 21, 2021
Added 50.0%
|